Ordr

The strongest AI centrality case in the cybersecurity lane, and graded above Asimily deliberately. The machine learning does the primary work rather than sitting on top of a lookup: behavioural fingerprinting trained on a stated 100 million-plus real-world devices performs classification, the system learns a behavioural baseline of normal communication per device, and segmentation policies are GENERATED from that learned behaviour rather than authored from templates. A customer account describes the platform learning normal behaviour and then automatically generating VLAN, ACL and firewall policies for engineers to review, attributing this to ML brought in by co-founder Sheausong Yang. The company states AI is a foundation built over a decade rather than a feature added recently, and that models are built on real device behaviour rather than synthetic data. Remove the models and there is no policy generation, no baseline and no anomaly detection.

The best autonomy design in this lane and directly responsive to the patient safety risk that defines it. Policies are generated automatically but SIMULATED AND VALIDATED BEFORE ENFORCEMENT, with the company describing a view showing every device group, allowed flow and policy gap, and the ability to simulate enforcement impact and see the blast radius before any rule changes. The customer account describes generated policies being presented for engineers to review and execute. That is the correct architecture where automatically isolating a misidentified infusion pump is a patient safety event rather than an outage: automate the analysis and the policy authoring, keep a human approval gate before enforcement, and make the consequence visible in advance. Ordr also differentiates from Armis and Claroty on this axis by combining intelligence and enforcement in one platform rather than requiring separate tooling, which is a claim buyers should verify but a coherent design position.

More specific than most security vendors. Training scale is quantified at over 100 million real-world devices, the input is named as proprietary device languages from thousands of manufacturers, the method is passive network traffic analysis with behavioural baselining, and the company states explicitly that models are built on real device behaviour rather than synthetic data. Graded B rather than A because no accuracy, false positive or device classification precision figures were located, and the index's category editorial specifically requires named detection methodologies rather than marketing language, which Ordr partially but not fully satisfies.

Named customer deployments with stated outcomes, which is better than most in this lane, though not independently audited. Healthcare implementations cited at Dayton Children's Hospital and Freeman Health System with documented risk reduction, plus reported protection of nearly two million connected devices across more than 500 organisations. Deployment claims are unusually specific and falsifiable: initial discovery completing within 48 to 72 hours and segmentation enforcement in weeks rather than months or years. Third party reference points exist including a KLAS 2026 Healthcare IoT Security score reported at 89.4, placing it credibly but below Asimily at 96.6. Graded B rather than A because outcome claims are vendor-reported without published methodology, and because a portion of the favourable comparative material originates from Ordr's own ranking content.

Structurally favourable for the same reason as Asimily: passive network traffic analysis with no agents and no active scanning means the platform observes device behaviour and communication metadata rather than ingesting clinical content, and it explicitly protects devices that cannot run security agents at all. Avoiding active scanning matters clinically, since scanning has historically crashed legacy medical devices. Graded B rather than A because clinical network traffic can carry PHI in protocol payloads and no published statement on handling incidental PHI was located.

HIPAA is addressed as a product capability, with continuous posture monitoring and automated evidence collection aligned to NIST, CIS, HIPAA and PCI frameworks to maintain audit readiness. Graded B rather than A because that is customer compliance tooling rather than a published statement of the vendor's own posture, and no BAA terms were located.

No third party attestation such as SOC 2 Type II or ISO 27001 was retrieved at the time of review. As with Asimily and Censinet, this is a pointed gap for a security vendor, and health system procurement will require it regardless of what the platform does for the customer's own compliance posture.

Not an FDA regulated product. The platform secures medical devices rather than performing a medical function. The operative constraint in this lane is the inverse: many clinical devices cannot be patched or modified without voiding manufacturer support or FDA validation, which is exactly why passive monitoring and network-level compensating controls such as segmentation dominate rather than endpoint remediation.

No governance framework or model evaluation disclosure located. The relevant risk class is not demographic but device coverage: systematic misclassification of uncommon equipment or failure to baseline rare device types would leave parts of a fleet silently unprotected, and generated segmentation policies built on an incorrect behavioural baseline could block legitimate clinical traffic. Policy simulation before enforcement mitigates the second risk operationally, but no published false negative or classification coverage analysis was located.

Correctly targeted at the systems that matter in this category and explicitly additive rather than replacing. The company states it enhances existing security infrastructure by integrating with firewalls, NAC, SIEM and other tools already in place, and the ranking criteria in this lane weight integration with CMMS, CMDB and SIEM specifically. Ordr automatically enriches the customer's CMDB with behaviour-based device intelligence, which is the practical difference between a security inventory and an authoritative asset record the whole organisation trusts. It also identifies devices lacking EDR or MDM coverage, closing the gap between the security tool estate and reality. Ordr IQ extends access beyond security teams, letting a facilities manager query maintenance schedules or IT pull end-of-life device lists from the same verified data.

Passive and agentless with no active scanning, which is the safest deployment posture available in clinical environments and is essential for the legacy and unmanaged devices that constitute much of the risk. Deployment timelines are stated and falsifiable: initial discovery within 48 to 72 hours, segmentation enforcement in weeks rather than the multi-year projects that characterise this work. The company also states policies are continuously refined as device behaviour evolves rather than being a one-time configuration. No data residency disclosure located, which is the only qualification on an otherwise strong axis.

No pricing published and no pricing basis disclosed, consistent with the rest of this lane. Given the platform combines discovery, risk prioritisation and segmentation enforcement in one product where competitors require additional tooling, the total cost comparison is genuinely difficult for buyers to construct from public information, and the vendor does not assist with it.

Broad across asset classes and industries while retaining genuine healthcare depth. Covers IT, IoT, OT, clinical and cloud assets in one platform, with healthcare-specific attention to connected medical equipment, IV pumps and imaging systems that cannot run agents. Serves more than 500 organisations spanning healthcare, banking, manufacturing, government and critical infrastructure. Functional span runs from discovery and inventory through vulnerability prioritisation, threat detection, segmentation policy generation and enforcement, to compliance evidence collection, which is a wider single-platform footprint than most competitors that stop at visibility.